glp-1 drug liraglutide may protect against dementia drugs tied to lower brain inflammation, higher depression risk Promising New Data Support GLP-1s

The Role of Prescribers in Closing the Gap The gap between what the clinical evidence supports and what patients typically receive as guidance when they are prescribed a GLP-1 is, in my experience, significant

doi: 10.1016/j.tem.2019.01.005 77 RutkowskaAZDiamanti-KandarakisE

[20] [18] The SUSTAIN-6 findings led to updates in FDA labeling for semaglutide, noting that patients with a history of diabetic retinopathy should be monitored for progression

Last month, The New York Times published an article that discusses how this phenomenon is playing out in people using these medications

Hereby, GLP-1RAs can diminish STAT1 activity [91]

These public behaviors highlight the value of capturing social media discussions and our pipeline to identify them